Cargando…

The Adapted POM Analysis of Avenanthramides In Silico

POM analysis and related approaches are significant tools based on calculating various physico-chemical properties and predicting biological activity, ADME parameters, and toxicity of a molecule. These methods are used to evaluate a molecule’s potential to become a drug candidate. Avenanthramides (A...

Descripción completa

Detalles Bibliográficos
Autores principales: Maliar, Tibor, Maliarová, Mária, Purdešová, Andrea, Jankech, Timotej, Gerhardtová, Ivana, Beňovič, Patrik, Dvořáček, Václav, Jágr, Michal, Viskupičová, Jana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224542/
https://www.ncbi.nlm.nih.gov/pubmed/37242500
http://dx.doi.org/10.3390/ph16050717
_version_ 1785050220217761792
author Maliar, Tibor
Maliarová, Mária
Purdešová, Andrea
Jankech, Timotej
Gerhardtová, Ivana
Beňovič, Patrik
Dvořáček, Václav
Jágr, Michal
Viskupičová, Jana
author_facet Maliar, Tibor
Maliarová, Mária
Purdešová, Andrea
Jankech, Timotej
Gerhardtová, Ivana
Beňovič, Patrik
Dvořáček, Václav
Jágr, Michal
Viskupičová, Jana
author_sort Maliar, Tibor
collection PubMed
description POM analysis and related approaches are significant tools based on calculating various physico-chemical properties and predicting biological activity, ADME parameters, and toxicity of a molecule. These methods are used to evaluate a molecule’s potential to become a drug candidate. Avenanthramides (AVNs) are promising secondary metabolites specific to Avena spp. (oat). They comprise the amides of anthranilic acid linked to various polyphenolic acids with or without post-condensation molecule transformation. These natural compounds have been reported to exert numerous biological effects, including antioxidant, anti-inflammatory, hepatoprotective, antiatherogenic, and antiproliferative properties. To date, almost 50 various AVNs have been identified. We performed a modified POM analysis of 42 AVNs using MOLINSPIRATION, SWISSADME, and OSIRIS software. The evaluation of primary in silico parameters revealed significant differences among individual AVNs, highlighting the most promising candidates. These preliminary results may help coordinate and initiate other research projects focused on particular AVNs, especially those with predicted bioactivity, low toxicity, optimal ADME parameters, and promising perspectives.
format Online
Article
Text
id pubmed-10224542
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102245422023-05-28 The Adapted POM Analysis of Avenanthramides In Silico Maliar, Tibor Maliarová, Mária Purdešová, Andrea Jankech, Timotej Gerhardtová, Ivana Beňovič, Patrik Dvořáček, Václav Jágr, Michal Viskupičová, Jana Pharmaceuticals (Basel) Article POM analysis and related approaches are significant tools based on calculating various physico-chemical properties and predicting biological activity, ADME parameters, and toxicity of a molecule. These methods are used to evaluate a molecule’s potential to become a drug candidate. Avenanthramides (AVNs) are promising secondary metabolites specific to Avena spp. (oat). They comprise the amides of anthranilic acid linked to various polyphenolic acids with or without post-condensation molecule transformation. These natural compounds have been reported to exert numerous biological effects, including antioxidant, anti-inflammatory, hepatoprotective, antiatherogenic, and antiproliferative properties. To date, almost 50 various AVNs have been identified. We performed a modified POM analysis of 42 AVNs using MOLINSPIRATION, SWISSADME, and OSIRIS software. The evaluation of primary in silico parameters revealed significant differences among individual AVNs, highlighting the most promising candidates. These preliminary results may help coordinate and initiate other research projects focused on particular AVNs, especially those with predicted bioactivity, low toxicity, optimal ADME parameters, and promising perspectives. MDPI 2023-05-09 /pmc/articles/PMC10224542/ /pubmed/37242500 http://dx.doi.org/10.3390/ph16050717 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Maliar, Tibor
Maliarová, Mária
Purdešová, Andrea
Jankech, Timotej
Gerhardtová, Ivana
Beňovič, Patrik
Dvořáček, Václav
Jágr, Michal
Viskupičová, Jana
The Adapted POM Analysis of Avenanthramides In Silico
title The Adapted POM Analysis of Avenanthramides In Silico
title_full The Adapted POM Analysis of Avenanthramides In Silico
title_fullStr The Adapted POM Analysis of Avenanthramides In Silico
title_full_unstemmed The Adapted POM Analysis of Avenanthramides In Silico
title_short The Adapted POM Analysis of Avenanthramides In Silico
title_sort adapted pom analysis of avenanthramides in silico
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224542/
https://www.ncbi.nlm.nih.gov/pubmed/37242500
http://dx.doi.org/10.3390/ph16050717
work_keys_str_mv AT maliartibor theadaptedpomanalysisofavenanthramidesinsilico
AT maliarovamaria theadaptedpomanalysisofavenanthramidesinsilico
AT purdesovaandrea theadaptedpomanalysisofavenanthramidesinsilico
AT jankechtimotej theadaptedpomanalysisofavenanthramidesinsilico
AT gerhardtovaivana theadaptedpomanalysisofavenanthramidesinsilico
AT benovicpatrik theadaptedpomanalysisofavenanthramidesinsilico
AT dvoracekvaclav theadaptedpomanalysisofavenanthramidesinsilico
AT jagrmichal theadaptedpomanalysisofavenanthramidesinsilico
AT viskupicovajana theadaptedpomanalysisofavenanthramidesinsilico
AT maliartibor adaptedpomanalysisofavenanthramidesinsilico
AT maliarovamaria adaptedpomanalysisofavenanthramidesinsilico
AT purdesovaandrea adaptedpomanalysisofavenanthramidesinsilico
AT jankechtimotej adaptedpomanalysisofavenanthramidesinsilico
AT gerhardtovaivana adaptedpomanalysisofavenanthramidesinsilico
AT benovicpatrik adaptedpomanalysisofavenanthramidesinsilico
AT dvoracekvaclav adaptedpomanalysisofavenanthramidesinsilico
AT jagrmichal adaptedpomanalysisofavenanthramidesinsilico
AT viskupicovajana adaptedpomanalysisofavenanthramidesinsilico